Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-10 Sale | 2026-02-12 4:08 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 12,101 | $5.3603 | $64,865 | 677,621 (Direct) | View |
| 2026-02-10 Sale | 2026-02-12 4:07 pm | Sagimet Biosciences Inc. | SGMT | Chauche Thierry Chief Financial Officer | 1,312 | $5.3603 | $7,033 | 15,688 (Direct) | View |
| 2026-02-10 Sale | 2026-02-12 4:06 pm | Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer | 3,640 | $5.3602 | $19,511 | 103,296 (Direct) | View |
| 2026-02-10 Sale | 2026-02-12 4:05 pm | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth Chief Legal & Admin. Officer | 2,622 | $5.3602 | $14,054 | 190,959 (Direct) | View |
| 2025-11-20 Sale | 2025-11-21 6:13 pm | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 37,688 | $7.6942 | $289,979 | 81,005 (Direct) | View |
| 2025-07-21 Sale | 2025-07-23 4:16 pm | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 65,478 | $9.1346 | $598,115 | 689,722 (Direct) | View |
| 2025-07-21 Sale | 2025-07-23 4:15 pm | Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer | 8,277 | $9.1346 | $75,607 | 106,936 (Direct) | View |
| 2025-07-21 Sale | 2025-07-23 4:14 pm | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO | 10,780 | $9.1346 | $98,471 | 183,726 (Direct) | View |
| 2024-07-23 Sale | 2024-07-25 4:05 pm | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 23,625 | $3.1674 | $74,830 | 118,693 (Direct) | View |
| 2024-07-19 Sale | 2024-07-23 4:06 pm | Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer | 8,357 | $3.1004 | $25,910 | 81,213 (Direct) | View |
| 2024-07-19 Sale | 2024-07-23 4:05 pm | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO | 10,914 | $3.0997 | $33,830 | 160,506 (Direct) | View |
| 2024-07-19 Sale | 2024-07-23 4:05 pm | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 14,062 | $3.1009 | $43,605 | 142,318 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-19 Option Award | 2026-02-20 4:43 pm | N/A 2036-02-18 | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth Chief Legal & Admin. Officer | 132,000 | $0 | 322,959 (Direct) | View |
| 2026-02-19 Option Award | 2026-02-20 4:42 pm | N/A 2036-02-18 | Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer | 132,000 | $0 | 235,296 (Direct) | View |
| 2026-02-19 Option Award | 2026-02-20 4:41 pm | N/A 2036-02-18 | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 384,000 | $0 | 1,061,621 (Direct) | View |
| 2026-02-19 Option Award | 2026-02-20 4:39 pm | N/A 2036-02-18 | Sagimet Biosciences Inc. | SGMT | Chauche Thierry Chief Financial Officer | 132,000 | $0 | 147,688 (Direct) | View |
| 2025-11-04 Option Award | 2025-11-06 4:43 pm | N/A 2035-11-03 | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth Chief Legal & Admin. Officer | 23,222 | $0 | 206,948 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 5:43 pm | N/A 2035-06-08 | Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director | 32,250 | $0 | 32,250 (Direct) | View |
| 2025-06-06 Option Award | 2025-06-10 5:42 pm | N/A 2035-06-05 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 60,772 | $0 | 60,772 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 5:41 pm | N/A 2035-06-08 | Sagimet Biosciences Inc. | SGMT | Phillips Anne M. Director | 27,268 | $0 | 27,268 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 5:40 pm | N/A 2035-06-08 | Sagimet Biosciences Inc. | SGMT | Kemble George Director | 32,250 | $0 | 32,250 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 5:38 pm | N/A 2035-06-08 | Sagimet Biosciences Inc. | SGMT | Jarrett Jennifer Director | 27,268 | $0 | 27,268 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 5:37 pm | N/A 2035-06-08 | Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director | 32,250 | $0 | 32,250 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-10 5:36 pm | N/A 2035-06-08 | Sagimet Biosciences Inc. | SGMT | GRAMMER ELIZABETH A Director | 32,250 | $0 | 32,250 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 4:44 pm | N/A 2035-02-05 | Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer | 172,000 | $0 | 253,213 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 4:43 pm | N/A 2035-02-05 | Sagimet Biosciences Inc. | SGMT | Happel David President & CEO | 588,000 | $0 | 1,227,200 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 4:42 pm | N/A 2035-02-05 | Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO | 172,000 | $0 | 332,506 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 4:41 pm | N/A 2035-02-05 | Sagimet Biosciences Inc. | SGMT | Chauche Thierry Chief Financial Officer | 86,000 | $0 | 86,000 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 4:09 pm | N/A 2034-07-31 | Sagimet Biosciences Inc. | SGMT | Jarrett Jennifer Director | 113,895 | $0 | 113,895 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 4:08 pm | N/A 2034-07-31 | Sagimet Biosciences Inc. | SGMT | Phillips Anne M. Director | 113,895 | $0 | 113,895 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:08 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director | 9,279 | $0 | 9,279 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:07 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director | 51,459 | $0 | 51,459 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:07 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | Parsey Merdad Director | 51,459 | $0 | 51,459 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:05 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director | 9,279 | $0 | 9,279 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:05 pm | N/A 2034-06-04 | Sagimet Biosciences Inc. | SGMT | GRAMMER ELIZABETH A Director | 51,459 | $0 | 51,459 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-08 4:06 pm | N/A 2034-05-05 | Sagimet Biosciences Inc. | SGMT | Chauche Thierry Chief Financial Officer | 587,181 | $0 | 587,181 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:19 pm | N/A 2034-03-31 | Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director | 73,014 | $0 | 73,014 (Direct) | View |